Epetome
Cambridge, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A biotech creating orally available peptide therapeutics for metabolic and cardiovascular diseases.
MetabolicCardiovascular
Technology Platform
An integrated platform for designing novel therapeutic peptides and formulating them for oral delivery through advanced encapsulation and permeation technologies.
Opportunities
Potential to disrupt large markets like diabetes and obesity with a convenient oral peptide therapy.
Risk Factors
High technical risk associated with achieving consistent and effective oral bioavailability for peptide drugs.
Competitive Landscape
Faces competition from numerous companies developing injectable peptide drugs and a few others pursuing the holy grail of oral peptide delivery.